April 27, 2020   Determining risk of ocular damage from chronic intravitreal injections Intravitreal injections used to treat a variety of ocular diseases may themselves contribute to progressive visual loss with chronic administration over years, according to researchers. Find out ADVERTISEMENT   Ranibizumab reported safe for bilateral macular degeneration Clinicians may safely use ranibizumab 0.5 mg in patients with bilateral AMD as well as those with BCVA of less than 2/10, an Italian real-life study suggests. Find out ADVERTISEMENT Managing patient visits amid the COVID-19 pandemic Retina specialist Rishi Singh, MD, shares an update on the precautions eye-care professionals and staff are taking at the Cole Eye Institute to ensure the health and safety of both patients and physicians during the coronavirus pandemic. Learn more ADVERTISEMENT   RELATED ARTICLES Autonomous diagnostics for DR: ‘Jump-start’ to AI ophthalmology DARPin molecule reducing wet AMD treatment burden for patients IRIS Registry study: Overall anti-VEGF injection intervals for wet AMD New model predicts ROP based on birth characteristics